Cochrane Abstracts
Aripiprazole for autism spectrum disorders (ASD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aripiprazole for Autism Spectrum Disorders (ASD)." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439984/all/Aripiprazole_for_autism_spectrum_disorders__ASD_.
Aripiprazole for autism spectrum disorders (ASD). Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439984/all/Aripiprazole_for_autism_spectrum_disorders__ASD_. Accessed November 22, 2024.
Aripiprazole for autism spectrum disorders (ASD). (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439984/all/Aripiprazole_for_autism_spectrum_disorders__ASD_
Aripiprazole for Autism Spectrum Disorders (ASD) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439984/all/Aripiprazole_for_autism_spectrum_disorders__ASD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aripiprazole for autism spectrum disorders (ASD)
ID - 439984
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439984/all/Aripiprazole_for_autism_spectrum_disorders__ASD_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
